Annual report pursuant to Section 13 and 15(d)

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)

12 Months Ended

Dec. 31, 2018

The following table summarizes the activity in the Company’s various classes of Preferred Stock included in Stockholders’ Deficit for the years ended December 31, 2018 and 2017:

	Series G				Series H						Series F				Series J				Total
	Shares		Amount		Shares			Amount			Shares		Amount		Shares		Amount		Shares			Amount
Balance December 31, 2016		215	$	2		10,019		$	100			-	$	-		-	$	-		10,234		$	102
Conversion of Series H Preferred Stock into common stock		-		-		(7,785	)		(78	)		-		-		-		-		(7,785	)		(78	)
Issuance of Series F Preferred Stock for business acquisition		-		-		-			-			1,750,000		17,500		-		-		1,750,000			17,500
Exchange of Series H Preferred Stock for convertible debentures		-		-		(2,174	)		(22	)		-		-		-		-		(2,174	)		(22	)
Balance December 31, 2017		215	$	2		60		$	0			1,750,000	$	17,500		-	$	-		1,750,275		$	17,502

	Series G				Series H					Series F				Series J				Total
	Shares		Amount		Shares			Amount		Shares		Amount		Shares		Amount		Shares			Amount
Balance December 31, 2017		215	$	2		60		$	-		1,750,000	$	17,500		-	$	-		1,750,275		$	17,502
Conversion of Series H Preferred Stock into common stock		-		-		(50	)				-		-		-		-		(50	)		-
Issuance of Series J Preferred Stock		-		-		-									250,000		2,500		250,000			2,500
Balance December 31, 2018		215	$	2		10		$	-		1,750,000	$	17,500		250,000	$	2,500		2,000,225		$	20,002

Schedule of Stock Option Activity

The following table summarizes the stock option activity for the years ended December 31, 2018 and 2017:

	Number of options			Weighted- average exercise price		Weighted- average contractual term
Outstanding at December 31, 2016		95		$	970,725		8.93
Granted		-
Expired		-
Forfeit		(18	)
Outstanding at December 31, 2017		77		$	1,035,374		8.33
Granted		-
Expired		-
Forfeit		-
Outstanding at December 31, 2018		77		$	1,036,374		7.33

Exercisable at December 31, 2018		68		$	1,152,616

Schedule of Stock Option Outstanding and Exercisable

The following table summarizes information with respect to stock options outstanding and exercisable by employees and directors at December 31, 2018:

Options outstanding										Options vested and exercisable
Exercise price		Number outstanding		Weighted average remaining contractual life (years)		Weighted average exercise		Aggregate intrinsic value		Number vested		Weighted average exercise		Aggregate intrinsic value
$	2,250,500		22		7.25			$	–		22	$	2,250,500	$	-
$	1,125,500		22		7.25				-		22	$	1,125,500		-
$	225,000		16		7.33				-		12	$	225,000		-
$	67,500		15		7.54				–		12	$	67,500		–
			77			$	1,036,374	$	–		68	$	1,152,616	$	–

Schedule of Warrants Activity

The following summarizes the information related to warrant activity during the years ended December 31, 2018 and 2017:

	Number of warrants			Weighted average exercise price
Balance at December 31, 2016		188		$	87,750.00
Increase in warrants during the period as a result of down round provisions		4,353,957		$	18.8119
Warrants exchanged during the period		(13	)	$	(93,525.00	)
March Warrants exercised during the period		(1,326	)	$	482.3643
Balance at December 31, 2017		4,352,806		$	22.1782
Increase in warrants during the period as a result of down round provisions		53,234,923,889
March Warrants expired during the period		(2,760,079	)	$	(0.1700	)
March Warrants exercised during the period		(106,006,177	)	$	(0.0419	)
Balance at December 31, 2018		53,130,510,439		$	0.0017